OncoDNA Competitors and Similar CompaniesClear all
OncoDNA's competitors and similar companies include Gamida Cell, Innate Pharma, Vivia Biotech and Turnstone Biologics.
 OncoDNA OncoDNA is a cancer theranostic company which uses a combination of the relevant molecular technologies to support oncologists in their treatment decisions for patients. |  Gamida Cell Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | |||
Founding Date | Founding Date 2012 | Founding Date 1998 | Founding Date 1999 | Founding Date 2007 | Founding Date 2015 |
Type | Type Private | Type Public | Type Public | Type Private | Type Public |
Tags | |||||
Locations | Locations Charleroi, BE HQ | Locations Boston, US HQ Jerusalem, IL | Locations Marseille, FR HQ Rockville, US | Locations Tres Cantos, ES HQ | Locations San Diego, US HQ Ottawa, CA |
Employees | Employees 502% increase | Employees 143175% increase | Employees 181 | Employees 28 | Employees 112 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 4.3 m | Valuation ($) 148.6 m | Valuation ($) N/A | Valuation ($) 11.6 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $1.8m (FY, 2023) | Revenue (est.) €2.8m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) N/A |
Cost of goods | Cost of goods N/A | Cost of goods $1.5m (FY, 2023) | Cost of goods €266k (FY, 2025) | Cost of goods N/A | Cost of goods N/A |
Gross profit | Gross profit N/A | Gross profit $330k (FY, 2023) | Gross profit €8.7m (FY, 2025) | Gross profit N/A | Gross profit N/A |
Net income | Net income N/A | Net income ($63m) (FY, 2023) | Net income (€49.2m) (FY, 2025) | Net income N/A | Net income ($70.8m) (FY, 2024) |
Funding | |||||
Latest funding round | Latest funding round $ 20.6m (over 6 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 9.4m (about 14 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 29.8m | Total funding raised $ 128.3m | Total funding raised $ 94.1m | Total funding raised $ 9.4m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Gamida Cell
HQ
Boston, US
Employees
143
Gamida Cell develops stem cell therapy technologies and products for the treatment of blood cancers, autoimmune and metabolic diseases.
View companyInnate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company
Vivia Biotech
HQ
Tres Cantos, ES
Employees
28
Vivia Biotech is a company specializing in providing individualized medicine.
View company
Turnstone Biologics
HQ
San Diego, US
Employees
112
Turnstone Biologics is an immuno-oncology company.
View company